|
Index of reports
> Cases with Dehydration (26)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Alimta (Pemetrexed) where reactions include dehydration. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Alimta side effects in
Reported by a consumer/non-health professional from Italy on 2012-06-25
Patient:
Reactions: Mucosal Inflammation, Vomiting, Diarrhoea, Dehydration, Febrile Neutropenia, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Alimta
Other drugs received by patient: Carboplatin
Possible Alimta side effects in male
Reported by a physician from France on 2012-06-20
Patient: male
Reactions: Malnutrition, General Physical Health Deterioration, Hyponatraemia, Arrhythmia, Hypokalaemia, Multi-Organ Failure, Dehydration, Venous Thrombosis, Colitis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Alimta
Other drugs received by patient: Candesartan Cilexetil; Oxycontin; Atenolol; Carboplatin; Adalat; Lovenox; Prozac; Fenofibrate
Possible Alimta side effects in male
Reported by a physician from United States on 2012-06-11
Patient: male
Reactions: Pneumonia Aspiration, Vomiting, Viral Infection, Hypotension, Hepatic Failure, Renal Failure, Respiratory Failure, Dehydration, White Blood Cell Analysis Decreased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Alimta
Other drugs received by patient: Cisplatin; Folic Acid
Possible Alimta side effects in male
Reported by a consumer/non-health professional from France on 2012-06-01
Patient: male
Reactions: Sepsis, Dehydration, Colitis, Pancytopenia, Nephrotic Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Alimta
Dosage: 1000 mg, unk
Indication: Lung Adenocarcinoma
Start date: 2012-02-21
Alimta
Dosage: 800 mg, unk
Start date: 2012-03-13
Other drugs received by patient: Cisplatin; Cisplatin; Neulasta
Possible Alimta side effects in male
Reported by a consumer/non-health professional from United States on 2012-05-25
Patient: male, weighing 101.2 kg (222.6 pounds)
Reactions: Agitation, Confusional State, Vomiting, Nausea, Metastases To Meninges, Dehydration, Metastases To Central Nervous System, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Alimta
Dosage: 500mg/m2, q 21days, iv
Indication: non-Small Cell Lung Cancer
Start date: 2010-04-09
Apricoxib / Placebo
Dosage: 400mg, daily, po
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2010-04-09
Possible Alimta side effects in male
Reported by a physician from United States on 2012-05-18
Patient: male
Reactions: Diarrhoea, Dehydration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Alimta
Other drugs received by patient: Carboplatin
Possible Alimta side effects in female
Reported by a consumer/non-health professional from United States on 2012-03-20
Patient: female
Reactions: Vomiting, Nausea, Dehydration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Alimta
Other drugs received by patient: Carboplatin; Avastin
Possible Alimta side effects in male
Reported by a physician from Japan on 2012-03-02
Patient: male, weighing 82.5 kg (181.5 pounds)
Reactions: Pneumonia Aspiration, Interstitial Lung Disease, Anaemia, Dehydration, Malnutrition, Lymphocyte Stimulation Test Positive, Rash
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Alimta
Other drugs received by patient: Fresmin S; Dextromethorphan Hydrobromide; Zolpidem; Candesartan Cilexetil and Hydrochlorothiazide; Panvitan; Goshajinkigan; Loxonin; Mucosta; Amlodipine
Possible Alimta side effects in male
Reported by a consumer/non-health professional from Japan on 2012-02-21
Patient: male, weighing 82.5 kg (181.5 pounds)
Reactions: Pneumonia Aspiration, Blood Lactate Dehydrogenase Increased, Malnutrition, Neoplasm Progression, Lung Adenocarcinoma Stage IV, Rash, Lymphocyte Stimulation Test Positive, Interstitial Lung Disease, Dehydration
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Alimta
Other drugs received by patient: Zolpidem; Mucosta; Goshajinkigan; Candesartan Cilexetil and Hydrochlorothiazide; Panvitan; Fresmin S; Amlodipine; Dextromethorphan Hydrobromide; Loxonin
Possible Alimta side effects in female
Reported by a consumer/non-health professional from Italy on 2012-02-21
Patient: female
Reactions: Weight Decreased, Vomiting, Nausea, Dehydration, Asthenia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Alimta
Other drugs received by patient: Cisplatin
Possible Alimta side effects in male
Reported by a physician from Italy on 2012-02-10
Patient: male
Reactions: Anaemia, Febrile Neutropenia, Rash, Ileus Paralytic, Death, Diarrhoea, Dehydration, Abdominal Distension, Thrombocytopenia, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Alimta
Dosage: 590 mg/total
Indication: Lung Adenocarcinoma Metastatic
Start date: 2011-01-13
Alimta
Dosage: 600 mg, unk
Start date: 2011-02-10
Possible Alimta side effects in male
Reported by a consumer/non-health professional from Italy on 2012-01-31
Patient: male
Reactions: Nausea, Hypophagia, Dehydration, Rash Papular, Paraesthesia
Drug(s) suspected as cause:
Alimta
Other drugs received by patient: Dobetin; Folic Acid; Cisplatin
Possible Alimta side effects in
Reported by a physician from Italy on 2012-01-20
Patient:
Reactions: Vomiting, Dehydration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Alimta
Possible Alimta side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-18
Patient: male, weighing 81.0 kg (178.2 pounds)
Reactions: Mental Status Changes, Oesophageal Ulcer, Blood Creatinine Increased, Renal Failure Acute, Inappropriate Schedule of Drug Administration, Stomatitis, Vomiting, Pneumonia, Nausea, Incorrect Dose Administered, Anaemia, Pancytopenia, Hypoaesthesia, Gastritis Haemorrhagic, Diarrhoea, Hypophagia, Dehydration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Erlotinib Hydrochloride
Dosage: 100 mg, cyclic (qd days 2-16)
Administration route: Oral
Indication: non-Small Cell Lung Cancer Stage IV
Start date: 2011-04-04
End date: 2011-10-09
Alimta
Dosage: 375 mg/m2, q3w
Indication: non-Small Cell Lung Cancer Stage IV
Start date: 2011-04-04
End date: 2011-09-28
Morphine
Dosage: unk
Indication: Pain
Other drugs received by patient: Amlodipine; Folic Acid; Citalopram; Zocor; Tamsulosin HCL; Clindamycin; Lomotil; Doxycycline; Gabapentin
Possible Alimta side effects in male
Reported by a physician from United States on 2011-12-23
Patient: male
Reactions: Somnolence, Off Label Use, Haematocrit Decreased, Fatigue, Aspiration, Dizziness, Hypoxia, Vomiting, Alanine Aminotransferase Increased, Sensation of Heaviness, Muscular Weakness, Toxicity To Various Agents, Haemoglobin Decreased, Diarrhoea, Blood Potassium Decreased, Hypophagia, Dehydration, Aspartate Aminotransferase Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Erlotinib Hydrochloride
Dosage: 150 mg, uid/qd
Administration route: Oral
Indication: Oropharyngeal Cancer Recurrent
Start date: 2011-10-12
External Beam Radiation Therapy
Dosage: weekly, ex. beam
Indication: Oropharyngeal Cancer Recurrent
Start date: 2011-10-13
Alimta
Dosage: unk
Indication: Oropharyngeal Cancer Recurrent
Miralax
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Erlotinib Hydrochloride
Dosage: 150 mg, uid/qd
Administration route: Oral
End date: 2011-10-28
Other drugs received by patient: Glimepiride; Lidoderm; Oxycodone HCL; Ativan; Folic Acid; Levothyroxine Sodium; Colace; Ativan; Neurontin; Ambien; Duragesic-100; Prochlorperazine Maleate; Zofran; Proair HFA
Possible Alimta side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-13
Patient: male, weighing 81.0 kg (178.2 pounds)
Reactions: Mental Status Changes, Oesophageal Ulcer, Thrombocytopenia, Blood Creatinine Increased, Renal Failure Acute, Inappropriate Schedule of Drug Administration, Pneumonia, Stomatitis, Vomiting, Nausea, Anaemia, Haemoglobin Abnormal, Incorrect Dose Administered, Pancytopenia, Hypoaesthesia, Gastritis Haemorrhagic, Diarrhoea, Hypophagia, Dehydration, Haematocrit Abnormal
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Alimta
Dosage: 375 mg/m2, q3w
Indication: non-Small Cell Lung Cancer Stage IV
Start date: 2011-04-04
End date: 2011-09-28
Morphine
Dosage: unk
Indication: Pain
Erlotinib Hydrochloride
Dosage: 100 mg, cyclic (qd days 2-16)
Administration route: Oral
Indication: non-Small Cell Lung Cancer Stage IV
Start date: 2011-04-04
End date: 2011-10-09
Other drugs received by patient: Clindamycin; Zocor; Doxycycline; Tamsulosin HCL; Amlodipine; Citalopram; Lomotil; Gabapentin; Folic Acid
Possible Alimta side effects in male
Reported by a physician from United States on 2011-12-12
Patient: male
Reactions: Vomiting, Alanine Aminotransferase Increased, Febrile Neutropenia, Muscular Weakness, Off Label Use, Fatigue, Diarrhoea, Aspiration, Dehydration, Hypophagia, Aspartate Aminotransferase Increased, Hypoxia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Alimta
Dosage: unk
Indication: Oropharyngeal Cancer Recurrent
External Beam Radiation Therapy
Dosage: weekly, ex. beam
Indication: Oropharyngeal Cancer Recurrent
Start date: 2011-10-13
Miralax
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Erlotinib Hydrochloride
Dosage: 150 mg, uid/qd
Administration route: Oral
End date: 2011-10-28
Erlotinib Hydrochloride
Dosage: 150 mg, uid/qd
Administration route: Oral
Indication: Oropharyngeal Cancer Recurrent
Start date: 2011-10-12
Other drugs received by patient: Colace; Folic Acid; Oxycodone HCL; Ativan; Levothyroxine Sodium; Glimepiride; Zofran; Proair HFA; Neurontin; Prochlorperazine Maleate; Ambien; Lidoderm; Ativan; Duragesic-100
Possible Alimta side effects in male
Reported by a physician from Italy on 2011-11-29
Patient: male
Reactions: Death, Diarrhoea, Anaemia, Dehydration, Febrile Neutropenia, Rash, Thrombocytopenia, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Alimta
Possible Alimta side effects in
Reported by a physician from Italy on 2011-11-17
Patient:
Reactions: Weight Decreased, Vomiting, Nausea, Dehydration, Asthenia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Alimta
Other drugs received by patient: Cisplatin
Possible Alimta side effects in male
Reported by a consumer/non-health professional from Italy on 2011-11-17
Patient: male
Reactions: Anaemia, Febrile Neutropenia, Rash, Death, Diarrhoea, Dehydration, Thrombocytopenia, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Alimta
Possible Alimta side effects in male
Reported by a consumer/non-health professional from United States on 2011-11-11
Patient: male, weighing 63.0 kg (138.7 pounds)
Reactions: Febrile Neutropenia, Pancytopenia, Failure To Thrive, Ascites, Diarrhoea, Neoplasm Malignant, Dehydration, Pleural Effusion, Asthenia, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Alimta
Dosage: unk, unknown
Start date: 2011-05-26
Alimta
Dosage: unk unk, unknown
Start date: 2011-03-17
Alimta
Dosage: unk, unknown
Indication: Lung Adenocarcinoma
Start date: 2011-01-02
Other drugs received by patient: Cisplatin
Possible Alimta side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-10
Patient: male, weighing 81.0 kg (178.2 pounds)
Reactions: Mental Status Changes, Blood Creatinine Increased, Thrombocytopenia, Oesophageal Ulcer, Inappropriate Schedule of Drug Administration, Pneumonia, Stomatitis, Vomiting, Nausea, Incorrect Dose Administered, Haemoglobin Abnormal, Anaemia, Hypoaesthesia, Gastritis Haemorrhagic, Diarrhoea, Hypophagia, Dehydration, Haematocrit Abnormal
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Alimta
Dosage: 375 mg/m2, q3w
Indication: non-Small Cell Lung Cancer
Start date: 2011-04-04
End date: 2011-09-28
Erlotinib Hydrochloride
Dosage: 100 mg, cyclic (qd days 2-16)
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2011-04-04
End date: 2011-10-09
Morphine
Dosage: unk
Indication: Pain
Possible Alimta side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-26
Patient: female, weighing 43.0 kg (94.6 pounds)
Reactions: Inappropriate Schedule of Drug Administration, Confusional State, Pneumonia, Incorrect Dose Administered, Dehydration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Alimta
Dosage: 715 mg, q3w
Indication: non-Small Cell Lung Cancer
Start date: 2011-06-09
End date: 2011-08-18
Erlotinib Hydrochloride
Dosage: 100 mg, days 2-19, cyclic
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2011-06-10
End date: 2011-08-25
Other drugs received by patient: Oxygen
Possible Alimta side effects in 36 year old male
Reported by a physician from United States on 2011-10-20
Patient: 36 year old male
Reactions: Productive Cough, Chills, Hypotension, Pain, Off Label Use, Malaise, Dehydration, Sepsis, Dizziness, Asthenia, Sinus Tachycardia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Alimta
Other drugs received by patient: Avastin; Oxycodone HCL; Fentanyl; Fentanyl; Marijuana; Erbitux
Possible Alimta side effects in 65 year old male
Reported by a consumer/non-health professional from United States on 2011-10-12
Patient: 65 year old male, weighing 77.0 kg (169.4 pounds)
Reactions: Hyperbilirubinaemia, Haemorrhage, Hypotension, Anaemia, Hypokalaemia, Mucosal Inflammation, Dehydration, Platelet Count Decreased, Hypocalcaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 1df=6auc inter on: 01jun2010.44d; restarted on 06jul2010 (3auc)
Indication: non-Small Cell Lung Cancer
Start date: 2010-04-19
Alimta
Dosage: inter on: 01jun2010.44d; restarted on 06jul2010 (250mg/m2)
Indication: non-Small Cell Lung Cancer
Start date: 2010-04-19
Other drugs received by patient: Ciprofloxacin; Emend; Xanax; Folic Acid; Vitamin B-12; Ondansetron HCL
Possible Alimta side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-12
Patient: male, weighing 84.0 kg (184.8 pounds)
Reactions: Pneumonia, Vomiting, Stomatitis, Nausea, Haemoglobin Abnormal, Mental Status Changes, Hypoaesthesia, Diarrhoea, Hypophagia, Dehydration, Thrombocytopenia, Haematocrit Abnormal
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Erlotinib Hydrochloride
Dosage: 100 mg, cyclic (qd days 2-16)
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2011-04-04
End date: 2011-09-18
Alimta
Dosage: 375 mg/m2, q3w
Indication: non-Small Cell Lung Cancer
Start date: 2011-04-04
Morphine
Dosage: unk
Indication: Pain
|
